SGEN - Seattle Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 518.27B
Enterprise Value 319.66B
Trailing P/E N/A
Forward P/E 1-90.09
PEG Ratio (5 yr expected) 1-1.75
Price/Sales (ttm)19.93
Price/Book (mrq)10.22
Enterprise Value/Revenue 321.45
Enterprise Value/EBITDA 6-99.92

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 345.81%
S&P500 52-Week Change 36.98%
52 Week High 3124.32
52 Week Low 362.90
50-Day Moving Average 3113.26
200-Day Moving Average 399.98

Share Statistics

Avg Vol (3 month) 31.09M
Avg Vol (10 day) 31.09M
Shares Outstanding 5171.39M
Float 120.14M
% Held by Insiders 10.76%
% Held by Institutions 1105.35%
Shares Short (Jan 14, 2020) 44.95M
Short Ratio (Jan 14, 2020) 44.13
Short % of Float (Jan 14, 2020) 44.57%
Short % of Shares Outstanding (Jan 14, 2020) 42.89%
Shares Short (prior month Dec 12, 2019) 45.11M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019


Profit Margin -17.31%
Operating Margin (ttm)-24.06%

Management Effectiveness

Return on Assets (ttm)-7.43%
Return on Equity (ttm)-10.07%

Income Statement

Revenue (ttm)916.71M
Revenue Per Share (ttm)5.54
Quarterly Revenue Growth (yoy)66.10%
Gross Profit (ttm)872.76M
EBITDA -196.77M
Net Income Avi to Common (ttm)-158.65M
Diluted EPS (ttm)-1.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)811.05M
Total Cash Per Share (mrq)4.72
Total Debt (mrq)67.61M
Total Debt/Equity (mrq)3.60
Current Ratio (mrq)4.54
Book Value Per Share (mrq)10.40

Cash Flow Statement

Operating Cash Flow (ttm)-163.74M
Levered Free Cash Flow (ttm)-263.46M